Insider · CIK 0001465837
Boxer Capital, LLC
Files at MRTX (Mirati Therapeutics, Inc.), TNGX (Tango Therapeutics, Inc.), TYRA (Tyra Biosciences, Inc.). First filing Oct 11, 2023, latest Oct 17, 2023.
In brief
Boxer Capital, LLC files SEC Form 4 as director at TNGX (Tango Therapeutics, Inc.), and also at MRTX (Mirati Therapeutics, Inc.), TYRA (Tyra Biosciences, Inc.). Since Oct 11, 2023, Boxer Capital, LLC has reported 2 open-market buys worth $17M and 1 open-market sell worth $2.2M, the latest filed on Oct 17, 2023.
A track record needs three past buys with six months of prices behind them; Boxer Capital, LLC has 2, so none is measured yet.
The newest scored trade: bought $8.7M of TNGX on Oct 13, 2023, filed Oct 17, 2023, scored 29 (weak), under a 10b5-1 plan.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TNGX: Tango Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 29Weak | Tango Therapeutics, Inc. | $8.7M 1,250,000 shares | +18% | +188% from low-36% from high | |
| 44Moderate | TNGXbuy Tango Therapeutics, Inc. | $8.7M 1,250,000 shares | +18% | +188% from low-36% from high | |
| 43Moderate | TNGXsell Tango Therapeutics, Inc. | $2.2M 225,000 shares | -30% | +270% from low-18% from high |
Transactions
Every row this insider has filed, 18 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 6, 2024 | TYRA Tyra Biosciences, Inc. | AGrant or award Common Stockindirect: See Footnote | +63,412 | $13.01 | $825k | 85,939 | Feb 8, 2024 |
| Feb 6, 2024 | TYRA Tyra Biosciences, Inc. | AGrant or award Warrant (right to purchase)derivative | +705,280 | $13.01 | $9.2M | 705,280 | Feb 8, 2024 |
| Jan 23, 2024 | MRTX Mirati Therapeutics, Inc. | DDisposition to issuer Common Stockindirect: See Footnote | -287,866 | - | - | 0 | Jan 25, 2024 |
| Jan 23, 2024 | MRTX Mirati Therapeutics, Inc. | DDisposition to issuer Common Stock | -3,201,440 | - | - | 0 | Jan 25, 2024 |
| Jan 23, 2024 | MRTX Mirati Therapeutics, Inc. | DDisposition to issuer Common Stockindirect: See Footnote | -203,754 | - | - | 0 | Jan 25, 2024 |
| Jan 23, 2024 | MRTX Mirati Therapeutics, Inc. | DDisposition to issuer Common Stockindirect: See Footnote | -3,135,966 | - | - | 0 | Jan 25, 2024 |
| Jan 23, 2024 | MRTX Mirati Therapeutics, Inc. | DDisposition to issuer Common Stockindirect: See Footnote | -30,518 | - | - | 0 | Jan 25, 2024 |
| Jan 23, 2024 | MRTX Mirati Therapeutics, Inc. | DDisposition to issuer Warrant (right to purchase)derivative | -332,809 | - | - | 0 | Jan 25, 2024 |
| Jan 23, 2024 | MRTX Mirati Therapeutics, Inc. | DDisposition to issuer Warrant (right to purchase)derivativeindirect: See Footnote | -3,578,036 | - | - | 0 | Jan 25, 2024 |
| Jan 23, 2024 | MRTX Mirati Therapeutics, Inc. | DDisposition to issuer Warrant (right to purchase)derivativeindirect: See Footnote | -1,413,475 | - | - | 0 | Jan 25, 2024 |
| Oct 13, 2023 | TNGX Tango Therapeutics, Inc. | POpen-market purchase Common Stock10b5-1 | +750,000 | $7.07 | $5.3M | 7,698,642 | Oct 17, 2023 |
| Oct 13, 2023 | TNGX Tango Therapeutics, Inc. | POpen-market purchase Common Stock | +750,000 | $7.07 | $5.3M | 7,698,642 | Oct 17, 2023 |
| Oct 16, 2023 | TNGX Tango Therapeutics, Inc. | POpen-market purchase Common Stock10b5-1 | +500,000 | $6.84 | $3.4M | 8,198,642 | Oct 17, 2023 |
| Oct 16, 2023 | TNGX Tango Therapeutics, Inc. | POpen-market purchase Common Stock | +500,000 | $6.84 | $3.4M | 8,198,642 | Oct 17, 2023 |
| Oct 9, 2023 | TNGX Tango Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote | -50,000 | $9.91 | $496k | 693,524 | Oct 11, 2023 |
| Aug 11, 2023 | TNGX Tango Therapeutics, Inc. | AGrant or award Common Stockindirect: See footnote | +475,000 | $5.15 | $2.4M | 743,542 | Oct 11, 2023 |
| Oct 9, 2023 | TNGX Tango Therapeutics, Inc. | SOpen-market sale Common Stock | -175,000 | $9.97 | $1.7M | 6,948,642 | Oct 11, 2023 |
| Aug 11, 2023 | TNGX Tango Therapeutics, Inc. | AGrant or award Prefunded Warrantderivative | +2,340,579 | $5.15 | $12M | 2,340,579 | Oct 11, 2023 |
Questions about Boxer Capital, LLC
Answered from the filings on this page, as of the latest one.
Is Boxer Capital, LLC buying or selling?
Not in the last 12 months. Boxer Capital, LLC's latest open-market trade on SEC Form 4 was bought $8.7M of TNGX on Oct 13, 2023.
How did Boxer Capital, LLC's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Boxer Capital, LLC has 2.
Where does Boxer Capital, LLC file Form 4?
Boxer Capital, LLC has filed Form 4 at TNGX (Tango Therapeutics, Inc.); MRTX (Mirati Therapeutics, Inc.); TYRA (Tyra Biosciences, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.